Detalles de la búsqueda
1.
Tailored immunotherapy approach with nivolumab with or without ipilimumab in patients with advanced transitional cell carcinoma after platinum-based chemotherapy (TITAN-TCC): a multicentre, single-arm, phase 2 trial.
Lancet Oncol
; 24(4): 347-359, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36868252
2.
Tailored immunotherapy approach with nivolumab with or without nivolumab plus ipilimumab as immunotherapeutic boost in patients with metastatic renal cell carcinoma (TITAN-RCC): a multicentre, single-arm, phase 2 trial.
Lancet Oncol
; 24(11): 1252-1265, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37844597
3.
Identification of bacteria in mixed infection from urinary tract of patient's samples using Raman analysis of dried droplets.
Analyst
; 148(16): 3806-3816, 2023 Aug 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37463011
4.
Focal bladder neck cautery associated with low rate of post-Aquablation bleeding.
Can J Urol
; 28(2): 10610-10613, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33872559
5.
Prostate cancer treated with image-guided helical TomoTherapy® and image-guided LINAC-IMRT : Correlation between high-dose bladder volume, margin reduction, and genitourinary toxicity.
Strahlenther Onkol
; 192(4): 223-31, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26742732
6.
Supraphysiological androgen levels induce cellular senescence in human prostate cancer cells through the Src-Akt pathway.
Mol Cancer
; 13: 214, 2014 Sep 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-25216853
7.
[Combination therapy with poly(adenosine diphosphate-ribose) polymerase (PARPi) and androgen receptor signaling pathway (ARPi) inhibitors for metastatic castration-resistant prostate cancer]. / Kombinationstherapie mit Inhibitoren der Poly(Adenosindiphosphat-Ribose)-Polymerasen (PARPi) und des Androgenrezeptorsignalweges (ARPi) beim metastasierten kastrationsrefraktären Prostatakarzinom.
Urologie
; 62(12): 1269-1280, 2023 Dec.
Artículo
en Alemán
| MEDLINE | ID: mdl-37978072
8.
[Antibody-drug conjugates as new therapeutic agents in uro-oncology]. / Antikörper-Wirkstoff-Konjugate als neues Wirkprinzip in der Uroonkologie.
Urologie
; 62(7): 679-684, 2023 Jul.
Artículo
en Alemán
| MEDLINE | ID: mdl-37294330
9.
67 Ga-PSMA I&T for Radioguided Surgery of Lymph Node Metastases in Patients With Biochemical Recurrence of Prostate Cancer.
Clin Nucl Med
; 48(7): 600-607, 2023 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37145416
10.
Rescue Allocation Modes in Eurotransplant Kidney Transplantation: Recipient Oriented Extended Allocation Versus Competitive Rescue Allocation-A Retrospective Multicenter Outcome Analysis.
Transplantation
; 2023 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38073036
11.
Management of Immune-Related Adverse Events from Immune-Checkpoint Inhibitors in Advanced or Metastatic Renal Cell Carcinoma.
Cancers (Basel)
; 14(18)2022 Sep 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36139530
12.
iRECIST-based versus non-standardized free text reporting of CT scans for monitoring metastatic renal cell carcinoma: a retrospective comparison.
J Cancer Res Clin Oncol
; 148(8): 2003-2012, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35420348
13.
Influence of Prostate Artery Embolization on Different Qualities of Lower Urinary Tract Symptoms Due to Benign Prostatic Obstruction.
Eur Urol Focus
; 8(5): 1323-1330, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35125344
14.
Interactions in cancer treatment considering cancer therapy, concomitant medications, food, herbal medicine and other supplements.
J Cancer Res Clin Oncol
; 148(2): 461-473, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33864520
15.
Complementary and alternative medicine (CAM) supplements in cancer outpatients: analyses of usage and of interaction risks with cancer treatment.
J Cancer Res Clin Oncol
; 148(5): 1123-1135, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-34228225
16.
Tailored Immunotherapy Approach With Nivolumab in Advanced Transitional Cell Carcinoma.
J Clin Oncol
; 40(19): 2128-2137, 2022 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35275706
17.
Risk Stratification and Treatment Algorithm of Metastatic Renal Cell Carcinoma.
J Clin Med
; 10(22)2021 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34830621
18.
[Side effects of immune checkpoint inhibitor treatment of urological tumors]. / Nebenwirkungen der Immun-Checkpoint-Inhibitor-Therapie urologischer Tumoren.
Urologe A
; 60(6): 803-815, 2021 Jun.
Artículo
en Alemán
| MEDLINE | ID: mdl-34100956
19.
Rate, Factors, and Outcome of Delayed Graft Function After Kidney Transplantation of Deceased Donors.
Transplant Proc
; 53(5): 1454-1461, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33612277
20.
New First Line Treatment Options of Clear Cell Renal Cell Cancer Patients with PD-1 or PD-L1 Immune-Checkpoint Inhibitor-Based Combination Therapies.
J Clin Med
; 9(2)2020 Feb 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-32092974